These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23816842)

  • 1. Costs of unnecessary admissions and treatments for "threatened preterm labor".
    Lucovnik M; Chambliss LR; Garfield RE
    Am J Obstet Gynecol; 2013 Sep; 209(3):217.e1-3. PubMed ID: 23816842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor.
    van Baaren GJ; Vis JY; Grobman WA; Bossuyt PM; Opmeer BC; Mol BW
    Am J Obstet Gynecol; 2013 Nov; 209(5):436.e1-8. PubMed ID: 23791688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic consequences of over-diagnosis of threatened preterm labor.
    Coloma M; Kang F; Vallejo-Torres L; Díaz P; Méndez Y; Álvarez de la Rosa M
    Int J Gynaecol Obstet; 2018 May; 141(2):200-205. PubMed ID: 29369336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvaginal cervical length measurement; its current application in a regional Australian level II maternity hospital.
    van Rijswijk S; Nagtegaal MJ; McGavin S; Dekker G
    Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):418-23. PubMed ID: 16171480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial.
    Grobman WA; Welshman EE; Calhoun EA
    Am J Obstet Gynecol; 2004 Jul; 191(1):235-40. PubMed ID: 15295372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of bedside fetal fibronectin testing varies according to treatment algorithm.
    Sullivan A; Hueppchen NA; Satin AJ
    J Matern Fetal Med; 2001 Dec; 10(6):380-4. PubMed ID: 11798447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In utero transfer for preterm labor: experience of a regional perinatal hotline providing a 24-hour on call service].
    Dupuis O; Arsalane A; Dupont C; Janvier M; Laurenceau N; Louzas I; Mikala M; Gariod S; Beaumont G; Rudigoz RC; Gaucherand P
    Gynecol Obstet Fertil; 2004 Apr; 32(4):285-92. PubMed ID: 15123097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of routine urine culture in the assessment of preterm labor.
    Hundley AF; Onderdonk AB; Greenberg JA
    J Reprod Med; 2003 Nov; 48(11):853-7. PubMed ID: 14686017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of a screen-and-treat program for asymptomatic vaginal infections in pregnancy: towards a significant reduction in the costs of prematurity.
    Kiss H; Pichler E; Petricevic L; Husslein P
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):198-203. PubMed ID: 16303228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical dilatation on presentation for preterm labor and subsequent preterm birth.
    How HY; Khoury JC; Sibai BM
    Am J Perinatol; 2009 Jan; 26(1):1-6. PubMed ID: 19021099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population.
    Groom KM; Liu E; Allenby K
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):440-5. PubMed ID: 16953860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cervical length to the efficacy of nifedipine and bed rest for inhibiting threatened preterm labor.
    Chawanpaiboon S; Sutantawibul A
    J Med Assoc Thai; 2012 May; 95(5):636-43. PubMed ID: 22994021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of hospitalizations for preterm labor in the United States.
    Nicholson WK; Frick KD; Powe NR
    Obstet Gynecol; 2000 Jul; 96(1):95-101. PubMed ID: 10862850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effective standardization of preterm labor evaluation.
    Rose CH; McWeeney DT; Brost BC; Davies NP; Watson WJ
    Am J Obstet Gynecol; 2010 Sep; 203(3):250.e1-5. PubMed ID: 20816147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome in women with preterm labor symptoms without cervical change.
    Rinehart BK; Terrone DA; Isler CM; Barrilleaux PS; Bufkin L; Morrison JC
    Am J Obstet Gynecol; 2001 Apr; 184(5):1004-7. PubMed ID: 11303212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic outcomes of preterm labor management: inpatient vs outpatient.
    Ambrose S; Rhea DJ; Istwan NB; Collins A; Stanziano G
    J Perinatol; 2004 Aug; 24(8):515-9. PubMed ID: 15141268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pronostic risk assessment of delivery, in patients admitted for threatened preterm birth, in a tertiary care maternity center].
    Berthelot-Ricou A; Tur S; Guidicelli B; Capelle M; Gamerre M; Courbiere B
    J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):600-9. PubMed ID: 24342367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinded comparison of cervical portio length measurements by digital examination vs Cervilenz.
    Burwick RM; Lee GT; Benedict JL; Ross MG; Kjos SL
    Am J Obstet Gynecol; 2009 May; 200(5):e37-9. PubMed ID: 19200931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.